Skip to main content
. 2017 Jun 2;12(6):e0178880. doi: 10.1371/journal.pone.0178880

Table 2. Metadata and phenotypic antimicrobial susceptibility for individual isolates.

Strain no. age date isolated siteb Antimicrobial compounda Ctrl/Csc
gender AMC SAM ATM FEP CAZ CTX IPM MEM AMK GEN TOB TET CIP LVX SXT
MHK00504 11m F 7/10/2010 Ku R R S S S S I S S S S R S S R ctrl
MHK01305 18yr 6m M 5/24/2011 Ki S R S S S S S S S S S R S S R cs
MHK01419 3yr 2m F 6/21/2011 Ki S R S S S S S S S R I R S S R ctrl
MHK01814 9m M 9/28/2011 Mb R R S S I S R S S S S R S S R cs
MHK02123d 21yr F 1/11/2012 Ki S I S S S S S S S S S R S S R ctrl
MHK02126d 1yr M 1/11/2012 Ki S S S S S S S S S S S S S S R ctrl
MHK02178 21yr M 1/21/2012 Ki R R S S S S I S S S S R S S R ctrl
MHK02303 2yr 1m F 2/11/2012 Ki R R S S S S S S S R I R S S R ctrl
MHK02499 1yr 3m M 3/29/2012 Ki I R R R ESBL ESBL S S S I S S S S R ctrl
MHK02590 6m M 4/14/2012 Mb R R R R R R S S R R R R R R R cs
MHK02631 54yr F 4/20/2012 Ki S S S S S S S S S S S R S S R ctrl
MHK02678 1yr 10m F 5/1/2012 Ki S S S S S S S S S S S S S S R ctrl
MHK02690 9m M 5/4/2012 Mb R R S S S S S S S S S I S S R cs
MHK02780 4m F 5/29/2012 Ki S S S S S S S S S S S R S S S cs
MHK03026 8yr F 7/13/2012 Ku I R S S S S S S S S S R S S R cs
MHK04212 11m M 11/15/2013 M1 R S S S S S S S S S S S S S R cs
MHK04617 5m M 11/16/2013 Mb I R S S S S S S S S S S S S R cs
MHK04622 8m M 11/20/2013 Ki S S S S S S S S S S S S S S S cs
MHK04775 2yr 1m F 2/1/2014 Ku S S S S S S S S S S S S S S R ctrl
MHK04776 2yr 6m F 2/1/2014 Ku I R S S S S S S S S S S S S R cs
MHK04777 51yr M 2/1/2014 Ko S R S S S S S S S S S R S S R ctrl
MHK04779 2yr 3m M 2/4/2014 Ke S S S S S S S S S S S S S S S cs
MHK04786 4yr M 2/5/2014 Ki I I S S S S S S S S S R S S R cs
MHK04792 43yr M 2/5/2014 Ke S S S S S S S S S S S R S S S ctrl
MHK04804 3yr 9m F 2/7/2014 Ki S R S S S S S S S S S R S S R ctrl
MHK04812 3yr M 3/27/2014 Ke R R S R ESBL ESBL S S S S S S S S R cs
MHK04813 1yr 2m M 3/28/2014 Ku I R S S S S S S S S S S S S R cs
MHK04819 1yr 4m M 4/1/2014 Ku S S S S S S S S S S S S S S R ctrl
MHK04821 2yr 3m F 4/2/2014 Ke S S S S S S S S S S S S S S S cs
MHK04822 2yr 11m M 4/3/2014 Ki S R S S S S S S S S S R S S R ctrl
MHK04834 19yr M 4/9/2014 Ko S S S S S S S S S S S I S S S ctrl
MHK04838 4yr F 4/10/2014 Ku S S S S S S S S S S S S S S S cs
MHK04847 28yr F 4/11/2014 Ko S S S S S S S S S S S R S S S cs
MHK04864 32yr F 4/17/2014 Ki S S S S S S S S S S S I S S S ctrl
MHK04872 22yr F 4/18/2014 Ku I R S S S S S S S S S R S S R cs
MHK04885 2yr 5m M 4/24/2014 Ke S S S S S S S S S S S R S S R cs
MHK04900 3yr 5m F 4/28/2014 Ke S S S S S S S S S S S S S S S ctrl
MHK04904 22yr F 4/29/2014 Ki S I S S S S S S S I S S S S R cs
MHK04908 1yr 3m M 4/30/2014 Ku S R S S S S S S S S S R S S R cs
MHK04919 3yr M 5/6/2014 Ki I R S S S S S S S S S S S S R ctrl
MHK04922 3yr F 5/7/2014 Ki R R R R R R I S R R R S S I R ctrl
MHK04923 24yr M 5/7/2014 Ki S S S S S S S R S S S S S S R ctrl
MHK04926 31yr F 5/7/2014 Ku S S S S S S S S S S S S S S R ctrl
MHK04928 5yr F 5/9/2014 Ki S S S S S S S S S S S S S S S ctrl
MHK04930 28yr M 5/9/2014 M1 R R R R ESBL ESBL S S S R R S S S R ctrl
MHK04941 1yr 8m M 5/14/2014 M1 R S S S S S S S S S S R S S R ctrl
MHK04943 28yr F 5/15/2014 Ki S S S S S S S S S S S S S S S cs
MHK04946 17yr F 5/16/2014 Ki S S S S S S S S S S S S S S S cs
MHK04947 36yr F 5/16/2014 Ko R R S S S S S S S S S I S S R cs
MHK04948 38yr M 5/16/2014 Ko S S S S S S S S S S S S S S S ctrl
MHK04957 37yr F 5/17/2014 M1 S S S S S I S S S S S I S S S cs
MHK04960 8m M 5/20/2014 Ki S S S S S S S S S S S S S S S ctrl
MHK04967 15yr M 5/22/2014 M1 I I S S S S S S S S S R S S R ctrl
MHK04980 30yr M 5/23/2014 M1 I I S S S S S S S S S R S S R cs
MHK04983 1yr 1m M 5/24/2014 Ku I R S S S S S S S S S R S S R ctrl
MHK04984 6m M 5/24/2014 Ku S S S S S S S S S S S S S S R ctrl
MHK05010 8yr F 5/31/2014 Ki I R R S S S S S S S S S S S R ctrl
MHK05013a 35yr F 5/31/2014 M1 S S S S S S S S S S S S S S R ctrl
MHK05013b 35yr F 5/31/2014 M1 S S S S S S S S S S S S S S R ctrl
MHK05014a 32yr M 5/31/2014 M1 S S S S S S S S S S S S S S S ctrl
MHK05014bd 32yr M 5/31/2014 M1 S S S S S S S S S S S S S S S ctrl
MHK05017 52yr F 6/5/2014 Ko S S S S S S S S S S S S S S R cs
MHK05018 32yr M 6/5/2014 M1 S S S S S S S S S S S S S S S ctrl
MHK05018-1b 32yr M 6/5/2014 M1 S S S S S S S S S S S S S S S ctrl
MHK05021 7yr M 6/5/2014 Ki S R S S S S S S S S S S S S R ctrl
MHK05027 7yr M 6/6/2014 Ki R R S S S S S S S S S R S S R cs
MHK05028 5yr F 6/6/2014 Ki S S S S S S S S S S S R S S R cs
MHK05042 2yr 9m M 6/11/2014 Ki R I S S S S S S S S S R S S R ctrl
MHK05046 4yr 10m M 6/12/2014 Ki S S S S S I S S S S S S S S S cs
MHK05068 6yr M 6/20/2014 Ki R R R R ESBL ESBL S S S R R S I S R cs
MHK05070 1yr F 6/21/2014 Ku S S S S S S S S S S S R S S R ctrl
MHK05072 4yr 6m F 6/21/2014 Ki S S S S S S S S S S S S S S S cs
MHK05080 9yr M 6/27/2015 Ki S S S S S S S S S S S I S S S cs
MHK05084 5yr F 6/28/2014 Ku R I S S S S S S S S S R S S S cs
MHK05090 4yr 6m M 7/2/2014 Ku S S S S S S S S S S S S S S S ctrl
MHK05091 5yr 10m M 7/2/2014 Ku R R R R ESBL ESBL S S S S S R S S R cs
MHK05094 23yr F 7/4/2014 Ki S S S S S S S S S S S S S S S ctrl
NTS01697 4yr 1m M 6/12/2014 Ki R R R R ESBL ESBL S I S R R S S R R cs
NTS01699 5yr 5m M 6/12/2014 Mg S S S S S S S S S S S I S S S cs
NTS01703 2yr 8m F 6/13/2014 Hy S S S S S S S S S S S R S S R cs
NTS01705 7m F 6/13/2014 Hy S R S R S S S S S S S S S S R cs
NTS01707 4yr 9m F 6/13/2014 Mg S S S S S S S S S S S R S S S ctrl
NTS01708 2yr 9m M 6/14/2014 Ki S S S S S S S S S S S S S S S cs
NTS01732 2yr 10m F 6/25/2014 Hy S S S S S S S S S S S S S S S cs
NTS01745 11m F 7/2/2014 Ki S S S S S S S S S S S S S S S cs
NTS01747 5yr M 7/3/2014 Hy S S S S S S S S S S S S S S R ctrl
NTS01749 4yr 3m M 7/3/2014 Mg S S S S S S S S S S S I S S S cs
NTS01755 3yr 1m F 7/5/2014 Ki I R S S S S S S S S S R S S R cs
NTS01793 3yr 2m M 8/2/2014 Hy S S I S S S S S S S S S S S S cs
NTS01936 5yr 6m M 6/26/2014 Mg S S S S S S S S S S S S S S S ctrl

aAntimicrobial compounds are grouped together according to categories used to define MDR per Magiorakos [22]. AMC–amoxicillin/clavulanate; SAM–ampicillin/sulbactam; ATM–aztreonam; FEP–cefepime; CAZ–ceftazidime; CTX–cefotaxime; IMP–imipenem; MEM–meropenem; AMK–amikacin; GEN–gentamicin; TOB–tobramycin; TET–tetracycline; CIP–ciprofloxacin; LVX–levofloxacin; SXT–trimethoprim/sulfamethoxazole; S–sensitive; I–intermediate; R–resistant. ESBL–Extended-spectrum β-lactamase

bCollection site: Hy–Homabay; Ke–Kericho; Ki–Kisii; Ko–Kombewa; Ku–Kisumu; Mb–Mbagathi; Mg–Migori; M1 –Moi Barracks at Eldoret

cctrl–healthy control; cs–case of acute diarrheal illness

dK. oxytoca